Subscribe to our Newsletters !!
Climate change is very disruptive to the Amazon ra
Weigh bridges are tools which are mostly used in v
Insects that are given more attention and reverenc
Alembic Pharmaceuticals Limited appoints Mr. Manis
The importance of comparing the treatment of asthm
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of The Magazine
Germany’s BioNTech and China’s Shanghai Fosun Pharmaceutical on Wednesday declared the start of another COVID-19 vaccine trial in China with a total of 144 participants.
“The study is designed to support the regulatory approval process for the Chinese market and plans to confirm the safety and immunogenicity profile observed in participants in the German and US trials is similar to that of Chinese participants,” BioNTech stated in a statement.